1. Carcinogenicity of 2-Amino-3-methylimidazo[4,5-f]quinoline in Nonhuman Primates: Induction of Tumors in Three Macaques
- Author
-
Dan W. Dalgard, Richard H. Adamson, Unnur P. Thorgeirsson, Snorri S. Thorgeirsson, Elizabeth G. Snyderwine, Takashi Sugimura, Shozo Takayama, and Jeanette Reeves
- Subjects
Heterocyclic amines ,Male ,Cancer Research ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,Hepatocellular carcinoma ,Physiology ,Biology ,Article ,chemistry.chemical_compound ,Liver Neoplasms, Experimental ,Animal model ,medicine ,Animals ,Nonhuman primates ,Carcinogen ,Quinoline ,medicine.disease ,Macaca fascicularis ,Liver ,Oncology ,chemistry ,Carcinogens ,Quinolines ,Female ,alpha-Fetoproteins - Abstract
The carcinogenic potential of 2‐amino‐3‐methylimidazo[4,5f]quinoline (IQ) was evaluated in cynomolgus monkeys. Monkeys received IQ, beginning at the age of one year, at doses of 10 or 20 mg/kg by gavage. Thus far, IQ has induced hepatocellular carcinoma in three monkeys with a latent period of 27 to 37 months. Metastases to the lung occurred in two of the three monkeys. Microscopically, the hepatocellular carcinoma in all three cases demonstrated a trabecular pattern. These data demonstrate that IQ is a potent carcinogen in nonhuman primates and support the idea that it is a potential carcinogen for humans.
- Published
- 1990
- Full Text
- View/download PDF